4-SUBSTITUTED PYRROLO[2,3-B]PYRIDINE AS ERBB MODULATORS USEFUL FOR TREATING CANCER
申请人:Lead Discovery Center GmbH
公开号:EP3613738A1
公开(公告)日:2020-02-26
The present invention relates to certain 4-substituted 1H-pyrrolo[2,3-b]pyridine compounds of the formula (I) and pharmaceutically acceptable salts thereof. These compounds is useful in the treatment or prevention of a disease or medical condition mediated through certain mutated forms of ErbB receptor, especially of Exon20 Her2 and EGFR mutations.
[EN] 4-SUBSTITUTED PYRROLO[2,3-B]PYRIDINE AS ERBB MODULATORS USEFUL FOR TREATING CANCER<br/>[FR] PYRROLO[2,3-B]PYRIDINE SUBSTITUÉE EN POSITION 4 EN TANT QUE MODULATEURS D'ERBB UTILES POUR LE TRAITEMENT DU CANCER
申请人:LEAD DISCOVERY CENTER GMBH
公开号:WO2020039060A1
公开(公告)日:2020-02-27
The present invention relates to certain 4-substituted 1H-pyrrolo[2,3-b]pyridine compounds of the formula (I) and pharmaceutically acceptable salts thereof. These compounds is useful in the treatment or prevention of a disease or medical condition mediated through certain mutated forms of ErbB receptor, especially of Exon20 Her2 and EGFR mutations.
Angyal; Jenkin, Australian Journal of Scientific Research, Series A: Physical Sciences, 1950, vol. <A> 3, p. 461,464